Why expanding access to Narcan in the US won’t solve the opioid crisis

1 year ago 46

Analysis Health

The US has made a medication that rapidly reverses opioid overdoses available without prescription – it will no doubt prevent some deaths, but it’s not enough to tackle the opioid epidemic

By Grace Wade

A two-pack of Narcan nasal spray, which is used to reverse opioid overdoses

Shutterstock/Bob LoCicero

For the first time, the US Food and Drug Administration (FDA) has approved a naloxone treatment – a drug called Narcan that rapidly reverses opioid overdoses – for use without a prescription. The decision is welcome news for a country in the midst of an ever-worsening opioid crisis. It will no doubt save lives, but it won’t turn the tide so long as treatment for opioid use disorder remains inaccessible.

For the past decade, the US has witnessed a …

View introductory offers

No commitment, cancel anytime*

Offer ends 14th June 2023.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account

More from New Scientist

Explore the latest news, articles and features

Popular articles

Trending New Scientist articles

Read Original